https://www.selleckchem.com/pr....oducts/cerdulatinib.
ctable cholangiocarcinoma. Utilizing a neoadjuvant approach including a second radical surgery will help to raise awareness for the necessity of radical surgery, especially second radical completion surgery in IGBC and improve the adherence to the guidelines. TRIAL REGISTRATION ClinicalTrials.gov ID NCT03673072 from 17.09.2018. EudraCT number 2017-004444-38 from 02.11.2017.BACKGROUND The global annual estimate for cryptococcal disease-related deaths exceeds 180,000, with three fourth occurring in sub-Saharan Africa. The World Healt
Respect!
Kommentar
Delen
